When to use a reduced NOAC dose
Patients receiving anticoagulation with a NOAC should receive a reduced dose in certain clinical situations
© 2017, Bayer AG. All rights reserved. Approval number: G.MKT.GM.XA.12.2017.2018
The management of thromboembolic disorders may be complicated by many factors, which need to be taken into consideration in both the prevention and treatment of VTE.
Non-modifiable factors that affect thrombosis management include the patient’s age, gender and prior medical conditions, such as previous history of DVT. Other factors include co-morbid medical conditions, such as cancer or heart disease, surgical treatment (irrespective of the type of surgery), immobility and pregnancy.